The Latin American nation, which has the third number of COVID-19 deaths worldwide, said Janssen Pharmaceuticals, a component of Johnson-Johnson, CanSino Biologics and Walvax Biotechnology, would begin Phase 3 trials starting Sept.
They will be registered with the French company Sanofi, which is also conducting the latest phase tests of a possible coronavirus vaccine in the country of more than 128 million.
After infection rates fell in Europe thanks to blocking measures, pharmaceutical corporations turned to the hardest-hit countries, such as Mexico, Brazil and South Africa, for large-scale trials of volunteer vaccines.
The government needs “Mexico to have quick access” to a coronavirus vaccine when it is ready, Chancellor Marcelo Ebrard said at a press conference.
Mexico said in direct contact with 15 of the most complex laboratories in the field.